Cassava Sciences (STU:PX91) General and Admin. Expense : €73.24 Mil (TTM As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Cassava Sciences General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Cassava Sciences's General and Admin. Expense for the three months ended in Mar. 2025 was €10.10 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2025 was €73.24 Mil.

Cassava Sciences General and Admin. Expense Historical Data

The historical data trend for Cassava Sciences's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cassava Sciences General and Admin. Expense Chart

Cassava Sciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

General and Admin. Expense

Get a 7-Day Free Trial

3.07

7.13

11.32

15.16

68.58

Cassava Sciences Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
General and Admin. Expense	Get a 7-Day Free Trial															3.41	42.92	11.67	8.55	10.10

Cassava Sciences General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €73.24 Mil.

Cassava Sciences General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Cassava Sciences's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Cassava Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cassava Sciences Inc (STU:PX91) » Definitions » General and Admin. Expense

Comparable Companies

Traded in Other Exchanges

SAVA:USA SAVA:Mexico PX91:Germany

Address

6801 N. Capital of Texas Highway, Suite 300, Building 1, Austin, TX, USA, 78731

Website

https://www.cassavasciences.com

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.

Cassava Sciences Headlines

No Headlines